Neuronetics, Inc. Increase (Decrease) in Other Operating Liabilities
Neuronetics, Inc. (STIM) reported Increase (Decrease) in Other Operating Liabilities of -$85.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-11
- Neuronetics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$255.00K.
- Neuronetics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $170.00K.
- Neuronetics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $480.00K, a 85.81% decline year-over-year.
- Neuronetics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $97.00K.
- Neuronetics, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was $257.00K.
- Neuronetics, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was -$66.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$255.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$85.00K 10-Q · filed 2026-08-11 | $395.00K derived: sum of 3 quarters · filed 2026-08-11 | $492.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $170.00K 10-Q · filed 2026-05-05 | $650.00K derived: sum of 2 quarters · filed 2026-05-05 | $747.00K derived: sum of 3 quarters · filed 2026-05-05 | $620.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $577.00K derived: sum of 2 quarters · filed 2026-03-17 | $450.00K derived: sum of 3 quarters · filed 2026-08-11 | $257.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$30.00K derived: sum of 2 quarters · filed 2026-08-11 | -$223.00K 10-Q · filed 2025-11-04 | $3.16M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$320.00K 10-Q · filed 2026-08-11 | $3.06M derived: sum of 3 quarters · filed 2026-08-11 | |
| 2025-03-31 | -$193.00K 10-Q · filed 2026-05-05 | $3.19M derived: sum of 2 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $3.38M derived: 10-K 12 month − 8-K/A 9 month · filed 2026-03-17 | -$66.00K 10-K · filed 2026-03-17 | ||
| 2024-09-30 | -$3.45M 8-K/A · filed 2025-02-06 | |||
| 2023-09-30 | -$750.00K 8-K/A · filed 2025-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |